
ATPC does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ATPC and 80,000+ other tickers.
See exactly how ATPC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ATPC and 80,000+ other tickers.
Agape ATP Corporation, an investment holding enterprise, operates out of Malaysia, providing a variety of health and wellness products in addition to health solution advisory services. The company structures its extensive offerings into four main program categories: ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S., each encompassing a unique selection of goods and services. Its product range includes the ATP series, featuring ATP1s Survivor Select for essential bodily nutrients, ATP3 Ionized Cal-Mag as a vital calcium and magnesium supplement, ATP4 Omega Blend supplying crucial…

Innovative Eyewear (NASDAQ: LUCY - Get Free Report) and Agape ATP (NASDAQ: ATPC - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Earnings and Valuation This table compares Innovative

OraSure Technologies (NASDAQ: OSUR - Get Free Report) and Agape ATP (NASDAQ: ATPC - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Analyst Recommendations This is a breakdown of

Agape ATP Corporation (NASDAQ: ATPC - Get Free Report) saw a significant decline in short interest in January. As of January 30th, there was short interest totaling 936,137 shares, a decline of 25.9% from the January 15th total of 1,263,530 shares. Currently, 1.9% of the shares of the stock are sold short. Based on an average

KUALA LUMPUR, MY / ACCESS Newswire / January 29, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it received a notification letter from the Listing Qualifications staff of The Nasdaq Stock Market LLC ("Nasdaq") on January 27, 2026, indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of US$1.00 per share for continued listing on the Nasdaq Capital Market. The notification was based on the closing bid price of the Company's common stock for the period from December 10, 2025 to January 26, 2026.

Agape ATP Corp. shares jumped 64.86% in after-hours trading after management addressed recent stock volatility.